Copper-related blood indexes in kidney dialysis patients

Nancy J. Emenaker, Robert A. DiSilvestro, Norris Stanley Nahman, Susan Percival

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Previous work has suggested that kidney hemodialysis patients could be at risk for either moderate copper deficiency or copper toxicity. The present study examined copper-related blood indexes in subjects undergoing hemodialysis treatments with membranes that are not copper-based, in subjects undergoing chronic ambulatory peritoneal dialysis (CAPD), and in control subjects. Both dialysis groups had low plasma copper and ceruloplasmin activities. This occurred despite high plasma interleukin 6 concentrations, a situation that usually elevates plasma ceruloplasmin and copper values. CAPD and hemodialysis subjects had low ratios of ceruloplasmin activity to immunoreactive protein, and low ratios of plasma copper to ceruloplasmin protein. Both are signs of copper deficiency. In contrast, copper-containing erythrocyte superoxide dismutase (SOD) activities were high in hemodialysis subjects and showed a nonsignificant trend toward high values in CAPD subjects. Blood mononuclear cell copper contents were highly variable within each group, and there were no significant differences between groups. In conclusion, ceruloplasmin-related indexes in kidney dialysis patients not dialyzed with copper based membranes suggested a tendency toward moderate copper deficiency. However, this contention could not be confirmed by erythrocyte SOD activity or mononuclear cell copper measurements.

Original languageEnglish (US)
Pages (from-to)757-760
Number of pages4
JournalAmerican Journal of Clinical Nutrition
Volume64
Issue number5
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Copper
Dialysis
Kidney
Ceruloplasmin
Renal Dialysis
Peritoneal Dialysis
Superoxide Dismutase
Erythrocytes
Membranes
Interleukin-6
Blood Cells
Proteins

Keywords

  • ceruloplasmin
  • Copper
  • dialysis
  • kidney
  • superoxide dismutase

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Copper-related blood indexes in kidney dialysis patients. / Emenaker, Nancy J.; DiSilvestro, Robert A.; Nahman, Norris Stanley; Percival, Susan.

In: American Journal of Clinical Nutrition, Vol. 64, No. 5, 01.01.1996, p. 757-760.

Research output: Contribution to journalArticle

Emenaker, Nancy J. ; DiSilvestro, Robert A. ; Nahman, Norris Stanley ; Percival, Susan. / Copper-related blood indexes in kidney dialysis patients. In: American Journal of Clinical Nutrition. 1996 ; Vol. 64, No. 5. pp. 757-760.
@article{dd169594dff84138a7fe1844d18dc649,
title = "Copper-related blood indexes in kidney dialysis patients",
abstract = "Previous work has suggested that kidney hemodialysis patients could be at risk for either moderate copper deficiency or copper toxicity. The present study examined copper-related blood indexes in subjects undergoing hemodialysis treatments with membranes that are not copper-based, in subjects undergoing chronic ambulatory peritoneal dialysis (CAPD), and in control subjects. Both dialysis groups had low plasma copper and ceruloplasmin activities. This occurred despite high plasma interleukin 6 concentrations, a situation that usually elevates plasma ceruloplasmin and copper values. CAPD and hemodialysis subjects had low ratios of ceruloplasmin activity to immunoreactive protein, and low ratios of plasma copper to ceruloplasmin protein. Both are signs of copper deficiency. In contrast, copper-containing erythrocyte superoxide dismutase (SOD) activities were high in hemodialysis subjects and showed a nonsignificant trend toward high values in CAPD subjects. Blood mononuclear cell copper contents were highly variable within each group, and there were no significant differences between groups. In conclusion, ceruloplasmin-related indexes in kidney dialysis patients not dialyzed with copper based membranes suggested a tendency toward moderate copper deficiency. However, this contention could not be confirmed by erythrocyte SOD activity or mononuclear cell copper measurements.",
keywords = "ceruloplasmin, Copper, dialysis, kidney, superoxide dismutase",
author = "Emenaker, {Nancy J.} and DiSilvestro, {Robert A.} and Nahman, {Norris Stanley} and Susan Percival",
year = "1996",
month = "1",
day = "1",
doi = "10.1093/ajcn/64.5.757",
language = "English (US)",
volume = "64",
pages = "757--760",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - Copper-related blood indexes in kidney dialysis patients

AU - Emenaker, Nancy J.

AU - DiSilvestro, Robert A.

AU - Nahman, Norris Stanley

AU - Percival, Susan

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Previous work has suggested that kidney hemodialysis patients could be at risk for either moderate copper deficiency or copper toxicity. The present study examined copper-related blood indexes in subjects undergoing hemodialysis treatments with membranes that are not copper-based, in subjects undergoing chronic ambulatory peritoneal dialysis (CAPD), and in control subjects. Both dialysis groups had low plasma copper and ceruloplasmin activities. This occurred despite high plasma interleukin 6 concentrations, a situation that usually elevates plasma ceruloplasmin and copper values. CAPD and hemodialysis subjects had low ratios of ceruloplasmin activity to immunoreactive protein, and low ratios of plasma copper to ceruloplasmin protein. Both are signs of copper deficiency. In contrast, copper-containing erythrocyte superoxide dismutase (SOD) activities were high in hemodialysis subjects and showed a nonsignificant trend toward high values in CAPD subjects. Blood mononuclear cell copper contents were highly variable within each group, and there were no significant differences between groups. In conclusion, ceruloplasmin-related indexes in kidney dialysis patients not dialyzed with copper based membranes suggested a tendency toward moderate copper deficiency. However, this contention could not be confirmed by erythrocyte SOD activity or mononuclear cell copper measurements.

AB - Previous work has suggested that kidney hemodialysis patients could be at risk for either moderate copper deficiency or copper toxicity. The present study examined copper-related blood indexes in subjects undergoing hemodialysis treatments with membranes that are not copper-based, in subjects undergoing chronic ambulatory peritoneal dialysis (CAPD), and in control subjects. Both dialysis groups had low plasma copper and ceruloplasmin activities. This occurred despite high plasma interleukin 6 concentrations, a situation that usually elevates plasma ceruloplasmin and copper values. CAPD and hemodialysis subjects had low ratios of ceruloplasmin activity to immunoreactive protein, and low ratios of plasma copper to ceruloplasmin protein. Both are signs of copper deficiency. In contrast, copper-containing erythrocyte superoxide dismutase (SOD) activities were high in hemodialysis subjects and showed a nonsignificant trend toward high values in CAPD subjects. Blood mononuclear cell copper contents were highly variable within each group, and there were no significant differences between groups. In conclusion, ceruloplasmin-related indexes in kidney dialysis patients not dialyzed with copper based membranes suggested a tendency toward moderate copper deficiency. However, this contention could not be confirmed by erythrocyte SOD activity or mononuclear cell copper measurements.

KW - ceruloplasmin

KW - Copper

KW - dialysis

KW - kidney

KW - superoxide dismutase

UR - http://www.scopus.com/inward/record.url?scp=0029911264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029911264&partnerID=8YFLogxK

U2 - 10.1093/ajcn/64.5.757

DO - 10.1093/ajcn/64.5.757

M3 - Article

VL - 64

SP - 757

EP - 760

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 5

ER -